Cargando…
‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities
The process of discovering new drugs has been extremely costly and slow in the last decades despite enormous investment in pharmaceutical research. Drug repurposing enables researchers to speed up the process of discovering other conditions that existing drugs can effectively treat, with low cost an...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869799/ https://www.ncbi.nlm.nih.gov/pubmed/27189611 http://dx.doi.org/10.1093/database/baw083 |
_version_ | 1782432377369264128 |
---|---|
author | Moosavinasab, Soheil Patterson, Jeremy Strouse, Robert Rastegar-Mojarad, Majid Regan, Kelly Payne, Philip R. O. Huang, Yungui Lin, Simon M. |
author_facet | Moosavinasab, Soheil Patterson, Jeremy Strouse, Robert Rastegar-Mojarad, Majid Regan, Kelly Payne, Philip R. O. Huang, Yungui Lin, Simon M. |
author_sort | Moosavinasab, Soheil |
collection | PubMed |
description | The process of discovering new drugs has been extremely costly and slow in the last decades despite enormous investment in pharmaceutical research. Drug repurposing enables researchers to speed up the process of discovering other conditions that existing drugs can effectively treat, with low cost and fast FDA approval. Here, we introduce ‘RE:fine Drugs’, a freely available interactive website for integrated search and discovery of drug repurposing candidates from GWAS and PheWAS repurposing datasets constructed using previously reported methods in Nature Biotechnology. ‘RE:fine Drugs’ demonstrates the possibilities to identify and prioritize novelty of candidates for drug repurposing based on the theory of transitive Drug–Gene–Disease triads. This public website provides a starting point for research, industry, clinical and regulatory communities to accelerate the investigation and validation of new therapeutic use of old drugs. Database URL: http://drug-repurposing.nationwidechildrens.org |
format | Online Article Text |
id | pubmed-4869799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48697992016-05-26 ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities Moosavinasab, Soheil Patterson, Jeremy Strouse, Robert Rastegar-Mojarad, Majid Regan, Kelly Payne, Philip R. O. Huang, Yungui Lin, Simon M. Database (Oxford) Database Tool The process of discovering new drugs has been extremely costly and slow in the last decades despite enormous investment in pharmaceutical research. Drug repurposing enables researchers to speed up the process of discovering other conditions that existing drugs can effectively treat, with low cost and fast FDA approval. Here, we introduce ‘RE:fine Drugs’, a freely available interactive website for integrated search and discovery of drug repurposing candidates from GWAS and PheWAS repurposing datasets constructed using previously reported methods in Nature Biotechnology. ‘RE:fine Drugs’ demonstrates the possibilities to identify and prioritize novelty of candidates for drug repurposing based on the theory of transitive Drug–Gene–Disease triads. This public website provides a starting point for research, industry, clinical and regulatory communities to accelerate the investigation and validation of new therapeutic use of old drugs. Database URL: http://drug-repurposing.nationwidechildrens.org Oxford University Press 2016-05-17 /pmc/articles/PMC4869799/ /pubmed/27189611 http://dx.doi.org/10.1093/database/baw083 Text en © The Author(s) 2016. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Database Tool Moosavinasab, Soheil Patterson, Jeremy Strouse, Robert Rastegar-Mojarad, Majid Regan, Kelly Payne, Philip R. O. Huang, Yungui Lin, Simon M. ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities |
title | ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities |
title_full | ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities |
title_fullStr | ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities |
title_full_unstemmed | ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities |
title_short | ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities |
title_sort | ‘re:fine drugs’: an interactive dashboard to access drug repurposing opportunities |
topic | Database Tool |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869799/ https://www.ncbi.nlm.nih.gov/pubmed/27189611 http://dx.doi.org/10.1093/database/baw083 |
work_keys_str_mv | AT moosavinasabsoheil refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities AT pattersonjeremy refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities AT strouserobert refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities AT rastegarmojaradmajid refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities AT regankelly refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities AT paynephilipro refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities AT huangyungui refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities AT linsimonm refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities |